Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Over the last 12 months, insiders at Becton, Dickinson and Company have bought $0 and sold $4.45M worth of Becton, Dickinson and Company stock.
On average, over the past 5 years, insiders at Becton, Dickinson and Company have bought $0 and sold $15.15M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 30 shares for transaction amount of $7,439 was made by BURZIK CATHERINE M (director) on 2019‑04‑16.
2024-06-10 | Sale | Spoerel Thomas J | SVP,Controller&Chief Acct Off | 300 0.0001% | $239.31 | $71,793 | -2.33% | |
2024-05-15 | Sale | Goette Roland | EVP and President EMEA | 3,300 0.0011% | $236.73 | $781,224 | -1.03% | |
2024-05-13 | Sale | Goette Roland | EVP and President EMEA | 3,300 0.0011% | $236.70 | $781,121 | -0.85% | |
2024-04-30 | Sale | Garrison Michael David | EVP & President Medical | 1,715 0.0006% | $232.81 | $399,269 | +0.16% | |
2024-03-14 | Sale | Spoerel Thomas J | SVP,Controller&Chief Acct Off | 282 <0.0001% | $238.29 | $67,198 | -0.51% | |
2023-12-11 | Sale | Garrison Michael David | EVP & President Medical | 1,239 0.0004% | $232.46 | $288,018 | +2.10% | |
2023-11-28 | Sale | Byrd Richard | EVP & President Interventional | 2,156 0.0007% | $238.47 | $514,141 | +0.01% | |
2023-09-05 | Sale | Byrd Richard | EVP & President Interventional | 459 0.0002% | $274.48 | $125,986 | -12.49% | |
2023-08-28 | Sale | Fraser Claire | director | 848 0.0003% | $281.66 | $238,848 | -15.16% | |
2023-08-11 | Sale | Hickey David | EVP & President, Life Sciences | 2,974 0.001% | $277.85 | $826,326 | -15.16% | |
2023-08-08 | Sale | Garrison Michael David | EVP & President Medical | 1,300 0.0005% | $277.13 | $360,269 | -14.65% | |
2023-02-03 | Sale | Byrd Richard | EVP & President Interventional | 1,421 0.0005% | $248.60 | $353,261 | +3.07% | |
2022-08-15 | Sale | Polen Thomas E Jr | Chairman, CEO and President | 9,500 0.0033% | $265.13 | $2.52M | -5.02% | |
2022-08-15 | Sale | Hickey David | EVP & President, Life Sciences | 475 0.0002% | $265.00 | $125,875 | -5.02% | |
2022-08-09 | Sale | Polen Thomas E Jr | Executive Vice President | 1,652 0.0006% | $260.00 | $429,520 | -0.74% | |
2022-08-09 | Sale | Khichi Samrat S. | EVP and General Counsel | 7,295 0.0026% | $260.44 | $1.9M | -0.74% | |
2022-06-07 | Sale | Spoerel Thomas J | VP Controller & Chief Acct Off | 443 0.0002% | $260.00 | $115,180 | -3.38% | |
2022-05-06 | Sale | Hickey David | EVP & President, Life Sciences | 950 0.0003% | $256.00 | $243,200 | -3.17% | |
2022-02-25 | Sale | Larson Betty D | EVP HR & CHRO | 601 0.0002% | $271.90 | $163,412 | -4.92% | |
2022-02-08 | Sale | Fraser Claire | director | 841 0.0003% | $271.70 | $228,500 | -5.95% |
Fraser Claire | director | 21608 0.0075% | $231.62 | 0 | 7 | |
Goette Roland | EVP and President, EMEA | 11308 0.0028% | $231.62 | 0 | 4 | |
Garrison Michael David | EVP & President Medical | 5381 0.0025% | $231.62 | 0 | 3 | |
Hickey David | EVP & President, Life Sciences | 4199 0.0015% | $231.62 | 0 | 4 | |
Byrd Richard | EVP & President Interventional | 4120 0.0014% | $231.62 | 0 | 3 | |
Spoerel Thomas J | VP Controller & Chief Acct Off | 1976 0.0004% | $231.62 | 0 | 7 | |
FORLENZA VINCENT A | Chairman of the Board | 208864 0.0723% | $231.62 | 0 | 26 | |
LUDWIG EDWARD J | Chairman | 97188 0.0336% | $231.62 | 0 | 39 | |
RING TIMOTHY M | director | 93688 0.0324% | $231.62 | 0 | 3 | |
CONSIDINE JOHN R | Vice Chairman | 89650 0.031% | $231.62 | 0 | 7 | |
COHEN GARY M | Executive Vice President | 71770 0.0248% | $231.62 | 0 | 21 | |
KOZY WILLIAM A | Executive Vice President | 68823 0.0238% | $231.62 | 0 | 23 | |
HANSON ALFRED JOHN | Executive Vice President | 40273 0.0139% | $231.62 | 0 | 5 | |
Polen Thomas E Jr | Chairman, CEO and President | 28878 0.01% | $231.62 | 0 | 10 | |
BECTON HENRY P JR | director | 23820 0.0082% | $231.62 | 0 | 56 | |
ORR JAMES F | director | 23045 0.008% | $231.62 | 0 | 3 | |
SCOTT BERTRAM L | director | 22416 0.0078% | $231.62 | 0 | 2 | |
SHERMAN JEFFREY S | Sr. VP and General Counsel | 22094 0.0076% | $231.62 | 0 | 17 | |
Conroy Alexandre | EVP of Integrated Supply Chain | 21260 0.0074% | $231.62 | 0 | 8 | |
Mecklenburg Gary A | director | 20965 0.0073% | $231.62 | 0 | 1 | |
OVERLOCK WILARD J JR | director | 21091 0.0073% | $231.62 | 2 | 2 | +1.24% |
Lim James C | Executive Vice President | 19768 0.0068% | $231.62 | 0 | 10 | |
DEGRAAN EDWARD | director | 18608 0.0064% | $231.62 | 0 | 1 | |
ANDERSON BASIL | director | 17221 0.006% | $231.62 | 0 | 1 | |
SOMMER ALFRED | director | 16228 0.0056% | $231.62 | 0 | 5 | |
Boles Donna M | Senior VP - Human Resources | 14607 0.0051% | $231.62 | 0 | 8 | |
TOZZI WILLIAM A | EVP Pres Interventional | 13208 0.0046% | $231.62 | 0 | 13 | |
Tharby Linda M | Executive Vice President | 11337 0.0039% | $231.62 | 0 | 4 | |
Campion Simon D | EVP and Segment President | 10773 0.0037% | $231.62 | 0 | 2 | |
RIMEL REBECCA W | director | 10618 0.0037% | $231.62 | 0 | 6 | |
Kaltenbach Patrick | EVP & Pres Life Sciences | 10340 0.0036% | $231.62 | 0 | 9 | |
BURZIK CATHERINE M | director | 10007 0.0035% | $231.62 | 3 | 1 | +5.53% |
UGGLAS MARGERETHA AF | director | 10000 0.0035% | $231.62 | 1 | 0 | +22.54% |
BEATY HARRY N | director | 9204 0.0032% | $231.62 | 0 | 1 | |
DURACK DAVID T | Senior Vice President | 8382 0.0029% | $231.62 | 0 | 22 | |
Mas Ribo Alberto | EVP and Pres, Life Sciences | 8381 0.0029% | $231.62 | 0 | 6 | |
Sichak Stephen | Executive Vice President | 7953 0.0028% | $231.62 | 0 | 11 | |
Shabshab Nabil | Executive Vice President | 7811 0.0027% | $231.62 | 0 | 5 | |
SHRADER PATRICIA B | Senior Vice President | 7915 0.0027% | $231.62 | 0 | 4 | |
Bruder Scott P | SrVP; Chief Technology Officer | 7626 0.0026% | $231.62 | 0 | 1 | |
Khichi Samrat S. | EVP and General Counsel | 5928 0.0021% | $231.62 | 0 | 3 | |
Strahlman Ellen R | Senior Vice President | 6037 0.0021% | $231.62 | 0 | 2 | |
Larson Betty D | EVP HR & CHRO | 5872 0.002% | $231.62 | 0 | 3 | |
Elkins David V | Executive VP and CFO | 5513 0.0019% | $231.62 | 0 | 1 | |
DAGEVILLE JEAN MARC | VP - Human Resources | 4658 0.0016% | $231.62 | 0 | 1 | |
Borzi James W | EVP & Chief Supply Chain Offcr | 2775 0.001% | $231.62 | 0 | 2 | |
Hurwitz Jerome V | Executive Vice President | 3027 0.001% | $231.62 | 0 | 4 | |
Minehan Cathy E. | director | 3000 0.001% | $231.62 | 2 | 0 | +2.05% |
Melcher David F | director | 2728 0.0009% | $231.62 | 1 | 0 | +8.76% |
Bodner Charles R | SVP Corp Fin Chief Acct Office | 2037 0.0007% | $231.62 | 0 | 2 | |
Gallagher John E | VP, Corp Finance and Treasurer | 2099 0.0007% | $231.62 | 0 | 5 |
The Vanguard Group | $6.48B | 9.06 | 26.18M | +0.23% | +$15.17M | 0.12 | |
BlackRock | $5.64B | 7.89 | 22.81M | +0.15% | +$8.37M | 0.13 | |
State Street | $3.35B | 4.68 | 13.53M | +4.77% | +$152.38M | 0.14 | |
Morgan Stanley | $2.65B | 3.71 | 10.71M | +0.01% | +$339,254.02 | 0.21 | |
T. Rowe Price | $2.5B | 3.5 | 10.12M | -2.56% | -$65.71M | 0.31 | |
T Rowe Price Investment Management Inc | $1.86B | 2.6 | 7.5M | +2.17% | +$39.39M | 1.14 | |
Geode Capital Management | $1.49B | 2.09 | 6.03M | +10.05% | +$135.91M | 0.13 | |
Massachusetts Financial Services Co Ma | $1.19B | 1.67 | 4.82M | +19.47% | +$194.29M | 0.36 | |
Wellington Management Company | $1.18B | 1.65 | 4.75M | -28.76% | -$474.81M | 0.2 | |
Ameriprise Financial | $1.18B | 1.64 | 4.75M | +12.36% | +$129.32M | 0.33 | |
JPMorgan Chase | $1.13B | 1.58 | 4.56M | -2.72% | -$31.59M | 0.1 | |
BNY Mellon | $1.01B | 1.41 | 4.07M | +4.42% | +$42.56M | 0.19 | |
Invesco | $985.41M | 1.38 | 3.98M | +5.98% | +$55.58M | 0.21 | |
Generation Investment Management Llp | $791.93M | 1.11 | 3.2M | +71.87% | +$331.16M | 3.62 | |
Franklin Templeton Investments | $766.55M | 1.07 | 3.1M | +0.87% | +$6.64M | 0.23 | |
ClearBridge Investments | $716.46M | 1 | 2.9M | -8.21% | -$64.11M | 0.57 | |
Northern Trust | $659.19M | 0.92 | 2.66M | -5.75% | -$40.2M | 0.11 | |
Mackenzie Financial Corp | $641.38M | 0.9 | 2.59M | -1.25% | -$8.13M | 0.87 | |
Mitsubishi UFJ Kokusai Asset Management | $628.44M | 0.88 | 2.54M | +4.35% | +$26.19M | 0.87 | |
Legal & General | $592.18M | 0.83 | 2.39M | -1.87% | -$11.31M | 0.14 | |
Longview Partners (Guernsey) LTD | $574.44M | 0.8 | 2.32M | +7.93% | +$42.19M | 3.71 | |
Vontobel Asset Management Inc | $598.14M | 0.79 | 2.28M | +10.59% | +$57.29M | 3.31 | |
Veritas Asset Management LLP | $536.18M | 0.75 | 2.17M | -0.75% | -$4.07M | 3.89 | |
First Eagle Investment Management | $523.35M | 0.73 | 2.11M | +8.24% | +$39.86M | 1.19 | |
Nordea Investment Management Ab | $478.3M | 0.67 | 1.94M | +277.29% | +$351.53M | 0.57 | |
Fiera Capital | $478.06M | 0.67 | 1.93M | -4.17% | -$20.81M | 1.4 | |
Teachers Pension Plan Board Ontario | $475M | 0.66 | 1.92M | +3.63% | +$16.65M | 4.43 | |
Amundi | $428.8M | 0.64 | 1.84M | -11.89% | -$57.85M | 0.18 | |
Bank of America | $450.75M | 0.63 | 1.82M | -67.06% | -$917.62M | 0.04 | |
American Century Investments | $450.48M | 0.63 | 1.82M | +14.93% | +$58.5M | 0.28 | |
Nuveen | $444.24M | 0.62 | 1.79M | +40.21% | +$127.4M | 0.13 | |
Wells Fargo | $421.27M | 0.59 | 1.7M | -54.41% | -$502.69M | 0.11 | |
CalPERS | $418.64M | 0.59 | 1.69M | -1.96% | -$8.36M | 0.29 | |
AllianceBernstein | $402.76M | 0.56 | 1.63M | +19.9% | +$66.84M | 0.14 | |
Charles Schwab | $398.47M | 0.56 | 1.61M | +2.49% | +$9.69M | 0.09 | |
Dimensional Fund Advisors | $388.3M | 0.54 | 1.57M | +4.08% | +$15.21M | 0.11 | |
Ubs Asset Management Americas Inc | $387.71M | 0.54 | 1.57M | -0.32% | -$1.23M | 0.14 | |
Diamond Hill Investment Group Inc | $349.43M | 0.49 | 1.41M | +22.85% | +$65M | 1.43 | |
Fidelity Investments | $337.79M | 0.47 | 1.37M | +1.57% | +$5.21M | 0.02 | |
Neuberger Berman | $333.9M | 0.47 | 1.35M | -24.02% | -$105.56M | 0.28 | |
Royal Bank of Canada | $318.24M | 0.45 | 1.29M | -18.53% | -$72.4M | 0.08 | |
Deutsche Bank | $248.04M | 0.35 | 1M | +7% | +$16.23M | 0.11 | |
Impax Asset Management Group | $243.34M | 0.34 | 985,782 | +7.16% | +$16.26M | 0.93 | |
Citadel Advisors LLC | $238.08M | 0.33 | 962,129 | -22.48% | -$69.04M | 0.15 | |
Jarislowsky Fraser Ltd | $221.76M | 0.31 | 896,176 | +3.63% | +$7.77M | 1.27 | |
Qube Research & Technologies | $219.72M | 0.31 | 887,944 | -26.14% | -$77.75M | 0.27 | |
Swiss National Bank | $214.56M | 0.3 | 867,102 | -4.42% | -$9.92M | 0.15 | |
Prudential Financial | $194.5M | 0.27 | 786,031 | +33.99% | +$49.34M | 0.27 | |
ProShares | $189.19M | 0.27 | 764,576 | +18.05% | +$28.93M | 0.5 | |
Cooke & Bieler, L.P. | $179.42M | 0.25 | 725,069 | +1.99% | +$3.5M | 1.66 |